Sonoma Pharmaceuticals, Inc. (SNOA)

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	19.53M	14.29M	12.74M	13.27M	12.63M
Pharmaceuticals Growth	36.68%	12.19%	-4.05%	5.10%	-32.21%
Total	19.53M	14.29M	12.74M	13.27M	12.63M
Total Growth	36.68%	12.19%	-4.05%	5.10%	-32.21%

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
United States	5.67M	2.61M	3.06M	3.43M	3.81M
United States Growth	117.31%	-14.62%	-10.79%	-9.96%	-29.75%
Europe	6.90M	5.52M	4.78M	4.05M	3.41M
Europe Growth	25.00%	15.52%	18.02%	18.80%	-
Asia	2.90M	2.32M	2.30M	2.45M	2.35M
Asia Growth	25.16%	0.83%	-6.24%	4.30%	-
Latin America	2.37M	2.96M	1.73M	2.38M	2.10M
Latin America Growth	-19.89%	71.61%	-27.57%	13.75%	-64.94%
Rest of The World	1.68M	875.00K	872.00K	959.00K	966.00K
Rest of The World Growth	91.77%	0.34%	-9.07%	-0.72%	-
Total	19.53M	14.29M	12.74M	13.27M	12.63M
Total Growth	36.68%	12.19%	-4.05%	5.10%	-32.21%

Data Source: S&P Global Market Intelligence Last updated: Feb 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 22, 2026

Data Sources Report a data error